Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms, Germ Cell and Embryonal × Cytosine Deaminase × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Neoplasms, Germ Cell and Embryonal 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 2 sodium thiosulfate 1 repotrectinib 1 pralsetinib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 Thrombopoietin 1 Plicamycin 1 Melphalan 1 Mannitol 1 ICE protocol 5 1 Etoposide 1 Drug Therapy 1 Cytosine Deaminase 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04657315 2023-01-18

MSC11FCD-GBM

CHA University

Phase 1/2 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡